“...the normal treatment for blood clots is to administer anticoagulants like heparin—but heparin can be harmful to people with CVST, so the FDA and CDC want providers to be aware of this rare condition and to know they must treat it differently.” vitals.lifehacker.com/what-you-need-…
I already tweeted this link, but I am sharing it again with that highlight, as, from all I am reading, it seems to be the big thing to know.
It isn’t ONLY the rare blood clots, but the KIND, which need DIFFERENT treatment from most, should they occur.
It isn’t ONLY the rare blood clots, but the KIND, which need DIFFERENT treatment from most, should they occur.
See also this thread:
https://twitter.com/aschwortz/status/1382008239064223747
(As always, I’m not a medical professional; in this particular case, a woman of the ages a week in on an J&J vaccine, so reading a lot today!)
in other words, as I understand it, if I develop a blood clot short term here, it is really important that it be known that I had J&J, because how I should be treated would be different than the usual
• • •
Missing some Tweet in this thread? You can try to
force a refresh
